{"id":4463,"date":"2025-09-19T17:17:24","date_gmt":"2025-09-20T00:17:24","guid":{"rendered":"https:\/\/wrwofficial.com\/index.php\/2025\/09\/19\/cdcs-vaccine-advisers-add-covid-vaccine-rules-in-contentious-meeting-shots\/"},"modified":"2025-09-19T17:17:30","modified_gmt":"2025-09-20T00:17:30","slug":"cdcs-vaccine-advisers-add-covid-vaccine-rules-in-contentious-meeting-shots","status":"publish","type":"post","link":"https:\/\/wrwofficial.com\/index.php\/2025\/09\/19\/cdcs-vaccine-advisers-add-covid-vaccine-rules-in-contentious-meeting-shots\/","title":{"rendered":"CDC’s vaccine advisers add COVID vaccine rules in contentious meeting : Shots"},"content":{"rendered":"

<\/p>\n

\n
\n
\n <\/picture>\n<\/div>\n
\n
\n
\n

\n ACIP member Retsef Levi speaks during a meeting of the CDC’s Advisory Committee on Immunization Practices on September 18, 2025 in Atlanta, Ga. The federal vaccine advisory group, recently appointed by Health Secretary Robert F. Kennedy Jr., made recommendations on the COVID vaccine.
\n <\/p>\n

Elijah Nouvelage\/Getty Images<\/p>\n

<\/b>
\n hide caption<\/b><\/b>\n <\/p>\n<\/p><\/div>\n

toggle caption<\/b><\/b>\n <\/div>\n

<\/p>\n

Elijah Nouvelage\/Getty Images<\/p>\n

<\/span>\n<\/div>\n<\/p><\/div>\n

A panel of vaccine advisers to the federal government debated several changes to COVID-19 vaccine access in a chaotic meeting Friday, marked by confusion over processes, technical difficulties and passionate disagreement among members and other experts in attendance.<\/p>\n

Ultimately, the Advisory Committee on Immunization Practices, or ACIP, backed away from its most controversial proposal that called for states to require those who want a COVID-19 vaccine to get a prescription. But the end result is that the COVID-19 vaccine could be less available than it has been the last few years.<\/p>\n

The group, which crafts recommendations on vaccine policy for the Centers for Disease Control and Prevention, voted to recommend vaccination for adults 65 and older and younger people, subject to a process called “shared decision making.” Their recommendations would not prohibit anyone over six months from getting the shot, but call for patients to speak with a clinician about the risks and benefits.<\/p>\n